Sulfur 8 Scalp Therapy Medicated Dandruff Control Leave-in Soothing Treatment Solution
FDA Label NDC 12022-033

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by J. Strickland And Co. for the product Sulfur 8 Scalp Therapy Medicated Dandruff Control Leave-in Soothing Treatment (NDC 12022-033). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, purpose, use:, warnings, ask a doctor before use, when using this product, stop use and consult a doctor if, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Active Ingredient

Salicylic Acid, 2%

Purpose

Antidandruff, Seborrheic Dermatitis, Psoriasis

Use:

for relief of scalp itching, irritation, redness, scaling and flaking associated with dandruff, seborrheic dermatitis, psoriasis.

Warnings

For external use only

Ask A Doctor Before Use

if the condition covers a large area of the body.

When Using This Product

avoid contact with eyes. If contact, rinse eyes thoroughly with water.

Stop Use And Consult A Doctor If

condition worsens or does not improve after regular use of this product as directed.

Keep Out Of Reach Of Children.

If swallowed, get medical help or contact a Poison Control Center right away.

Flammable Keep away from heat and open flame.

Directions

Apply to the affected area one to four times daily or as directed by a doctor. Use after shampooing or between shampoos.

Inactive Ingredients

Water, SD Alcohol 40, Propylene Glycol, Benzyl Alcohol, Menthol, Fragrance

* Please review the disclaimer below.